The simultaneous inhibition of the transcription factors Myc and JunB could represent a pioneering therapeutic option for the ...

The first patient blood samples, just weeks away, will open a new chapter in medicine’s ongoing search for a therapy that ...

CTCs are rare cancer cells that tumors shed in the blood. They've been looked at before in prostate cancer, but only in its ...

Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...

For some patients with breast cancer, ctDNA may have the potential to predict disease relapse after they have undergone ...

T cell therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors. A study demonstrates that a different immunotherapy approach ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond ...

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

As cancer hospitals focus on initiatives to enable healthier populations and eradicate the disease, they must navigate ...

In the medical field, being fast, efficient, and correct can be the difference between life and death. This game-changing ...

A medical clinic in Scottsdale, Arizona, offers an alternative, personalized form of chemotherapy designed to target cancer ...